The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Abstract
BACKGROUND: The development of tumor necrosis factor alpha (TNF-alpha) antagonists has made it feasible to investigate the role of this cytokine in refractory asthma. METHODS: We measured markers of TNF-alpha activity on peripheral-blood monocytes in 10 patients with refractory asthma, 10 patients with mild-to-moderate asthma, and 10 control subjects. We also investigated the effects of treatment with the soluble TNF-alpha receptor etanercept (25 mg twice weekly) in the patients with refractory asthma in a placebo-controlled, double-blind, crossover pilot study. RESULTS: As compared with patients with mild-to-moderate asthma and controls, patients with refractory asthma had increased expression of membrane-bound TNF-alpha, TNF-alpha receptor 1, and TNF-alpha-converting enzyme by peripheral-blood monocytes. In the clinical trial, as compared with placebo, 10 weeks of treatment with etanercept was associated with a significant increase in the concentration of methacholine required to provoke a 20 percent decrease in the forced expiratory volume in one second (FEV1) (mean difference in doubling concentration changes between etanercept and placebo, 3.5; 95 percent confidence interval, 0.07 to 7.0; P=0.05), an improvement in the asthma-related quality-of-life score (by 0.85 point; 95 percent confidence interval, 0.16 to 1.54 on a 7-point scale; P=0.02), and a 0.32-liter increase in post-bronchodilator FEV1 (95 percent confidence interval, 0.08 to 0.55; P=0.01). CONCLUSIONS: Patients with refractory asthma have evidence of up-regulation of the TNF-alpha axis. (ClinicalTrials.gov number, NCT00276029.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationMast-Cell Infiltration of Airway Smooth Muscle in Asthma
Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., & Pavord, I. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012705 · Cited by 1,241
Self-citationWENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Kriegler, M., Perez, C., DeFay, K., Albert, I., & Lu, S. D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,102
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909
Measuring Quality of Life in Asthma
Juniper, E. F., Guyatt, G. H., Ferrie, P. J., & Griffith, L. E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.832 · Cited by 887
Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H., & Holgate, S. T. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179909 · Cited by 830
Self-citationThe ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
Cytokines in symptomatic asthma airways
Broide, D. H., Lotz, M., Cuomo, A. J., Coburn, D. A., Federman, E. C., & Wasserman, S. I. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90218-q · Cited by 736
Kharitonov, S., Alving, K., & Barnes, P. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10071683 · Cited by 664
Cited by
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
“recent genomic and proteomic approaches have suggested increases in IL-1β in certain asthmatics, in conjunction with neutrophilia [107-109].”
BackgroundSelf-citationTNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
“A pilot study of patients with refractory asthma provided evidence for a role of TNF, and demonstrated a beneficial effects of etanercept on markers of asthma control [138].”
BackgroundBritish Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Self-citationAsthma: defining of the persistent adult phenotypes
Wenzel, S. E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69290-8 · Cited by 1,043
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 940
HOLGATE, S. T. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02971.x · Cited by 809
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Treatment strategies for allergy and asthma
Holgate, S. T., & Polosa, R. (2008) · Nature Reviews Immunology · doi:10.1038/nri2262 · Cited by 691
Role of TNFα in pulmonary pathophysiology
Mukhopadhyay, S., Hoidal, J. R., & Mukherjee, T. K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-125 · Cited by 576
The role of the mast cell in the pathophysiology of asthma
Bradding, P., Walls, A. F., & Holgate, S. T. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.039 · Cited by 573
Self-citationIncreased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells
Préfontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemière, C., Martin, J. G., & Hamid, Q. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802387 · Cited by 538
Immunologic mechanisms in asthma
Boonpiyathad, T., Sözener, Z. C., Satitsuksanoa, P., & Akdis, C. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101333 · Cited by 489
Wenzel, S. E., Barnes, P. J., Bleecker, E. R., Bousquet, J., Busse, W., Dahlén, S.-E., Holgate, S. T., Meyers, D. A., Rabe, K. F., Antczak, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1512oc · Cited by 460
T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
Choy, D. F., Hart, K. M., Borthwick, L. A., Shikotra, A., Nagarkar, D. R., Siddiqui, S., Jia, G., Ohri, C. M., Doran, E., Vannella, K. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3142 · Cited by 450
Self-citationVandivier, R. W., Henson, P. M., & Douglas, I. S. (2006) · Chest · doi:10.1378/chest.129.6.1673 · Cited by 450
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
IL-23 and Th17 Cells Enhance Th2-Cell–mediated Eosinophilic Airway Inflammation in Mice
Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S.-I., Suto, A., Watanabe, N., Saito, Y., Hatano, M., Tokuhisa, T., Iwakura, Y., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-086oc · Cited by 437
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0006-6 · Cited by 418
The mechanisms, diagnosis, and management of severe asthma in adults
Holgate, S. T., & Polosa, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69288-x · Cited by 398
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma
An, S. S., Bai, T. R., Bates, J. H. T., Black, J. L., Brown, R. H., Brusasco, V., Chitano, P., Deng, L., Dowell, M., Eidelman, D. H., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00112606 · Cited by 383
Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma
Sutherland, E. R., Goleva, E., Jackson, L. P., Stevens, A. D., & Leung, D. Y. M. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1710oc · Cited by 377
Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
Edwards, M. R., Bartlett, N. W., Clarke, D., Birrell, M., Belvisi, M., & Johnston, S. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.003 · Cited by 375
“Recent clinical research programs have focused on anti-TNF-α antibodies or soluble TNF-α receptors as a therapy (Howarth et al., 2005; Berry et al., 2006; Erin et al., 2006; Morjaria et al., 2008) , highlighting the importance of inflammation as well as Th2 responses in asthma.”
BackgroundTargeting TNF-α: A novel therapeutic approach for asthma
Brightling, C., Berry, M., & Amrani, Y. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.028 · Cited by 363
Self-citationPathophysiology of allergic inflammation
Barnes, P. J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01020.x · Cited by 361
Fajt, M. L., & Wenzel, S. E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1871 · Cited by 353
Eosinophilic and Noneosinophilic Asthma
Carr, T. F., Zeki, A. A., & Kraft, M. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2232pp · Cited by 351
Body Mass and Glucocorticoid Response in Asthma
Sutherland, E. R., Goleva, E., Strand, M., Beuther, D. A., & Leung, D. Y. M. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-076oc · Cited by 347
Asthma exacerbations: Origin, effect, and prevention
Jackson, D. J., Sykes, A., Mallia, P., & Johnston, S. L. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.024 · Cited by 343
Bel, E. H., Sousa, A., Fleming, L., Bush, A., Chung, K. F., Versnel, J., Wagener, A. H., Wagers, S. S., Sterk, P. J., Compton, C. H., et al. (2011) · Thorax · doi:10.1136/thx.2010.153643 · Cited by 343
Diver, S., Khalfaoui, L., Emson, C., Wenzel, S. E., Menzies-Gow, A., Wechsler, M. E., Johnston, J., Molfino, N., Parnes, J. R., Megally, A., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00226-5 · Cited by 328
Self-citationMast cells in the promotion and limitation of chronic inflammation
Metz, M., Grimbaldeston, M. A., Nakae, S., Piliponsky, A. M., Tsai, M., & Galli, S. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00520.x · Cited by 302
Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples
Baines, K. J., Simpson, J. L., Wood, L. G., Scott, R. J., & Gibson, P. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.024 · Cited by 298
Therapies for allergic inflammation: refining strategies to induce tolerance
Akdis, C. A. (2012) · Nature Medicine · doi:10.1038/nm.2754 · Cited by 296
Importance of Cytokines in Murine Allergic Airway Disease and Human Asthma
Finkelman, F. D., Hogan, S. P., Hershey, G. K. K., Rothenberg, M. E., & Wills-Karp, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902185 · Cited by 293
Severe asthma in adults: What are the important questions?
Chanez, P., Wenzel, S. E., Anderson, G. P., Anto, J. M., Bel, E. H., Boulet, L.-P., Brightling, C. E., Busse, W. W., Castro, M., Dahlen, B., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.702 · Cited by 277
Self-citationOboki, K., Ohno, T., Saito, H., & Nakae, S. (2008) · Allergology International · doi:10.2332/allergolint.r-07-160 · Cited by 271
Noneosinophilic asthma: A distinct clinical and pathologic phenotype
Haldar, P., & Pavord, I. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.042 · Cited by 263
Self-citationTargeting the interleukin pathway in the treatment of asthma
Chung, K. F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00157-9 · Cited by 261
Mechanisms and therapeutic strategies for non‐T2 asthma
Sze, E., Bhalla, A., & Nair, P. (2020) · Allergy · doi:10.1111/all.13985 · Cited by 259
Phthalate exposure and long-term epigenomic consequences: a review
Dutta, S., Haggerty, D. K., Rappolee, D. A., & Ruden, D. M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00405 · Cited by 212
Healthy immune response to allergens: T regulatory cells and more
Akdis, M. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.06.003 · Cited by 174
Severe asthma: Advances in current management and future therapy
Barnes, P. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.006 · Cited by 174
Macrophage heterogeneity in respiratory diseases
Boorsma, C. E., Draijer, C., & Melgert, B. N. (2013) · Mediators of Inflammation · doi:10.1155/2013/769214 · Cited by 126
Effects of phthalate exposure on asthma may be mediated through alterations in DNA methylation
Wang, I.-J., Karmaus, W. J., Chen, S.-L., Holloway, J. W., & Ewart, S. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0060-x · Cited by 97
Novel Biologicals for the Treatment of Allergic Diseases and Asthma
Tan, H.-T. T., Sugita, K., & Akdis, C. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0650-5 · Cited by 68
Asthma in the Precision Medicine Era: Biologics and Probiotics
Chiu, C.-J., & Huang, M.-T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094528 · Cited by 60
Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies
Kane, B., Fowler, S. J., & Niven, R. (2015) · Chronic Respiratory Disease · doi:10.1177/1479972314562210 · Cited by 15
Metadata
- Authors
- Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-02-16
- Volume
- 354
- Issue
- 7
- Pages
- 697-708
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2170599998
- Cited by
- 826
- References
- 25
- FWCI
- 59.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.